- No file added yet -
Patients’ experiences during the long journey before initiating migraine prevention with a calcitonin gene-related peptide (CGRP) monoclonal antibody (mAb)
Version 2 2024-09-20, 08:38
Version 1 2024-09-10, 14:40
media
posted on 2024-09-20, 08:38 authored by Adis journals on behalf Adis journals on behalf of, Elizabeth Seng, Christian Lampl, Lars Viktrup, William R. Lenderking, Hayley Karn, Margaret Hoyt, Gilwan Kim, Dustin Ruff, Michael H. Ossipov, Maurice VincentThe above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
